Clara Houdayer,A Marie Phillips,Marie Chabbert,Jennifer Bourreau,Reza Maroofian,Henry Houlden,Kay Richards,Nebal Waill Saadi,Eliška Dad’ová,Patrick Van Bogaert,Mailys Rupin,Boris Keren,Perrine Charles,Thomas Smol,Audrey Riquet,Lynn Pais,Anne O’Donnell-Luria,Grace E. VanNoy,Allan Bayat,Rikke S Møller,Kern Olofsson,Rami Abou Jamra,Steffen Syrbe,Majed Dasouki,Laurie H Seaver,Jennifer A Sullivan,Vandana Shashi,Fowzan S Alkuraya,Alexis F Poss,J Edward Spence,Rhonda E Schnur,Ian C Forster,Chaseley E Mckenzie,Cas Simons,Min Wang,Penny Snell,Kavitha Kothur,Michael Buckley,Tony Roscioli,Noha Elserafy,Benjamin Dauriat,Vincent Procaccio,Daniel Henrion,Guy Lenaers,Estelle Colin,Nienke E. Verbeek,Koen L. Van Gassen,Claire Legendre,Dominique Bonneau,Christopher A Reid,Katherine B Howell,Alban Ziegler,Christian Legros

Abstract:Hyperpolarization activated Cyclic Nucleotide (HCN) gated channels are crucial for various neurophysiological functions, including learning and sensory functions, and their dysfunction are responsible for brain disorders, such as epilepsy. To date, variants have only been associated with mild epilepsy and recently, one monoallelic missense variant has been linked to developmental and epileptic encephalopathy. Here, we expand the phenotypic spectrum of related disorders by describing twenty-one additional individuals from fifteen unrelated families carrying variants. Seventeen individuals had developmental delay/intellectual disability (DD/ID), two had borderline DD/ID, and one had borderline DD. Ten individuals had epilepsy with DD/ID, with median age of onset of 10 months, and one had epilepsy with normal development. Molecular diagnosis identified thirteen different pathogenic variants, including eleven missense variants affecting highly conserved amino acids, one frameshift variant, and one in-frame deletion. Seven variants were monoallelic of which five occurred one was not maternally inherited, one was inherited from a father with mild learning disabilities, and one was of unknown inheritance. The remaining six variants were biallelic, with four homozygous and two compound heterozygous variants. Functional studies using two-electrode voltage-clamp recordings in oocytes were performed on three monoallelic variants, p.(Arg324His), p.(Ala363Val), and p.(Met374Leu), and three biallelic variants, p.(Leu377His), p.(Pro493Leu) and p.(Gly587Asp). The p.(Arg324His) variant induced a strong increase of HCN2 conductance, while p.(Ala363Val) and p.(Met374Leu) displayed dominant negative effects, leading to a partial loss of HCN2 channel function. By confocal imaging, we found that the p.(Leu377His), p.(Pro493Leu) and p.(Gly587Asp) pathogenic variants impaired membrane trafficking, resulting in a complete loss of HCN2 elicited currents in oocytes. Structural 3D-analysis in depolarized and hyperpolarized states of HCN2 channels, revealed that the pathogenic variants p.(His205Gln), p.(Ser409Leu), p.(Arg324Cys), p.(Asn369Ser) and p.(Gly460Asp) modify molecular interactions altering HCN2 function. Taken together, our data broadens the clinical spectrum associated with variants, and disclose that is involved in developmental encephalopathy with or without epilepsy.

POLR3B is associated with a developmental and epileptic encephalopathy with myoclonic‐atonic seizures and ataxia

POLR3B de novo variants are a rare cause of infantile myoclonic epilepsy

Recessive mutations in POLR1C cause a leukodystrophy by impairing biogenesis of RNA polymerase III

Craniofacial features of POLR3-related leukodystrophy caused by biallelic variants in POLR3A, POLR3B and POLR1C

Compound heterozygous mutations in POLR3A gene cause global developmental delay with epilepsy and striatal degeneration

POLR3-related leukodystrophy caused by biallelic POLR3A and 1C pathogenic variants: a single-center experience

Novel Mutations of the POLR3A Gene Caused POLR3-related Leukodystrophy in a Chinese Family: a Case Report

De novo truncating variants in the intronless IRF2BPL are responsible for developmental epileptic encephalopathy

Bi-allelic POLR3A Loss-of-Function Variants Cause Autosomal-Recessive Wiedemann-Rautenstrauch Syndrome.

A POLR3B-variant reveals a Pol III transcriptome response dependent on La protein/SSB

Rare GABRA3 variants are associated with epileptic seizures, encephalopathy and dysmorphic features.

Biallelic EPB41L3 variants underlie a developmental disorder with seizures and myelination defects

New evidence supports RYR3 as a candidate gene for developmental and epileptic encephalopathy

Variants of ATP1A3 in residue 756 cause a separate phenotype of relapsing encephalopathy with cerebellar ataxia (RECA)-Report of two cases and literature review

Molecular basis of neurodegeneration in a mouse model of Polr3 -related disease

Spatially clustering de novo variants in CYFIP2, encoding the cytoplasmic FMRP interacting protein 2, cause intellectual disability and seizures

Mono and biallelic variants in cause severe neurodevelopmental disorders

Missense variants in RPH3A cause defects in excitatory synaptic function and are associated with a clinically variable neurodevelopmental disorder

De novo variants in GABRA4 are associated with a neurological phenotype including developmental delay, behavioral abnormalities and epilepsy

Specific Combinations of Biallelic POLR3A Variants Cause Wiedemann-Rautenstrauch Syndrome.

A Novel Variant of the POLR3A Gene in a Chinese Patient with POLR3-related Leukodystrophy